Skip to content
Pill with imprint L22, brown, round, 6 mm (Levothyroxine Sodium 0.125 mg)

L22 pill

Pill with imprint L22 is brown, round, 6 mm and has been identified as Levothyroxine Sodium 0.125 mg. It is used for goiter, myxedema and thyroid neoplasms. It is supplied by Nucarepharmaceuticals, Inc.

Levothyroxine Sodium 0.125 mg

Imprint
L22
Strength
0.125 mg
Used for
Goiter, myxedema and thyroid neoplasms
Color
Brown
Shape
Round
Size
6 mm
Score
Breaks into 2 pieces
Form
Tablet
Manufacturer
Nucarepharmaceuticals, Inc
Drug class
Thyroid hormone
NDC
68071-3692, 68180-971, 68071-3692-9, 68180-971-01, 68180-971-02, 68180-971-03, 68180-971-09, 60687-519, 60687-519-11, 60687-519-01, 0904-6955, 0904-6955-61, 50090-6983, 50090-6983-0, 50090-6982, 50090-6982-1, 50090-6982-0, 51655-484, 51655-484-52, 51655-484-26, 82804-246, 82804-246-30, 67046-0951, 67046-0951-3, 55154-3562, 55154-3562-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Levothyroxine pills and guides

What is Levothyroxine used for?

Levothyroxine is used for goiter, myxedema and thyroid neoplasms.

Medicine type
Thyroid hormone
Official uses from the US prescribing label

Hypothyroidism

Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.

Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression

Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.

Limitations of Use

  • Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism.
  • Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.

From the FDA-approved label on DailyMed (published Sep 24, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows L22.
  • It is brown, round, 6 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Levothyroxine Sodium

Inactive: Croscarmellose Sodium, Fd&c Blue No. 1, Fd&c Blue No. 2, Fd&c Red No. 40, Fd&c Yellow No. 6, Magnesium Stearate, Mannitol, Sodium Bicarbonate, Starch, Corn

Also distributed by

Lupin Pharmaceuticals, Inc., American Health Packaging, Major Pharmaceuticals, A-S Medication Solutions, Northwind Health Company, LLC, Proficient Rx LP, Coupler LLC, Cardinal Health 107, LLC

Other pills with imprint L22

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Levothyroxine pills